Category: Regulations
-
FDA Halts Off-the-Shelf Engineered T-Cell Trial
A company designing gene-edited T-cells as cancer therapies stopped its clinical trial of a treatment for multiple myeloma when a patient in the trial died.
-
FDA Sets Review Criteria for Covid-19 Vaccines
The Food and Drug Administration issued its standards that developers need to meet in evidence submitted for review of vaccines to prevent Covid-19 infections.
-
Infographic – Steps to Control Covid-19 Transmission
The Lancet prepared a chart with the most effective measures for controlling person-to-person transmission, reproduced as this weekend’s infographic.
-
Convalescent Plasma Found Safe as Covid-19 Therapy
Donated blood plasma from people who recovered from Covid-19 infections is found to cause few serious side effects when given as a treatment for infections in others.
-
FDA Clears Video Game ADHD Therapy
A video game designed to help children improve their inattention and other symptoms of ADHD received authorization from the U.S. Food and Drug Administration.
-
Economic Model IDs Pandemic Business Opening Risks
As communities try to manage their economies during the Covid-19 pandemic, three economists offer a model to help decide which businesses to open after shutting down.
-
Weak Covid-19 App Privacy Found, Risk Software in Works
An analysis of mobile apps tracking Covid-19 cases and symptoms finds most lack basic privacy protections, despite collecting personal identifying information.
-
Infographic – Major Cities Far Short of Herd Immunity
The data show in major American and European cities, as well as Wuhan, China, the percentage of the population with antibodies against the coronavirus.
-
FDA Analyzing Real-World Evidence on Covid-19
The Food and Drug Administration is analyzing collections of health records to gain more evidence-based insights into the course of the Covid-19 pandemic.
-
FDA Stops Home Covid-19 Diagnostic Test
The Food and Drug Administration asked designers of a Covid-19 test collecting samples at home for research to stop giving results to individuals.